This article showcases our top picks for the best London based Health Diagnostics companies. These startups and companies are taking a variety of approaches to innovating the Health Diagnostics industry, but are all exceptional companies well worth a follow.
We tried to pick companies across the size spectrum from cutting edge startups to established brands.
We selected these startups and companies for exceptional performance in one of these categories:
- Innovative ideas
- Innovative route to market
- Innovative product
- Exceptional growth
- Exceptional growth strategy
- Societal impact
Top London Health Diagnostics Companies
Babylon is a digital health service provider that combines AI technology with the medical expertise of humans. Babylon delivers full access to healthcare, including personalized health assessments, treatment advice, and face-to-face appointments with a doctor 24/7.
Babylon’s mission is to put an accessible and affordable health service in the hands of every person on earth. With the Babylon app, you can talk to a physician within minutes via phone or video call, ask simple medical questions via their text service and monitor your health with their comprehensive tracking system.
The Babylon app is everything you need to proactively manage your healthcare.. .
LumiraDx helps achieve better health care, social care, and financial outcomes, affordably, in the here and now. It offers proven solutions to help achieve your health care transformation goals, practically and reliably, in the here and now.
The company’s clients universally deliver more integrated, more informed, patient-centered care that is safer, more efficient, and with demonstrably better outcomes. LumiraDx makes diagnostic-led care simpler and more accessible with smarter connected diagnostics and diagnostic-led care solutions to enable better outcomes: better health, better experiences, and better value.
The diagnostic system platform combines a small, portable instrument, advanced low-cost test strip, and seamless digital connectivity.. .
Healthcare marketplace is broken from a long-time. Both buyers (hospitals, health systems) and suppliers (pharmaceutical and medical device manufacturers/digital health companies/service or solution providers) struggle to find the optimum opportunities for developing a transaction.
It takes time and resources to effectively commercialise new healthcare technology. We use the latest data automation technologies (NLP, ML, DL etc).
to aggregate demand from millions of sources and provide real-time analytics to shape the transaction. We aggregate more than $2tn of global demand (70+ countries) in our system and make it easier for healthcare companies to start closing more deals.
Our customers use a range of search and bid-development tools within our platform to quickly find the most suitable opportunity and finalise a transaction. Additionally, buyers (hospital, clinics etc.) can directly launch procurement and sourcing programs in our platform and get access to thousands of suppliers in the market for their respective products/services.
We have millions of contracts in our platform across countries for suppliers to bid, we have onboarded some of the world’s most innovative healthcare companies, we are continuing to raise money to build the world’s first digital marketplace, we have won innovation awards, and we’re backed by some of the best investors in the world. And we are JUST GETTING STARTED..
Just-Eat’s parent company is Just-Eat Holdings Limited.. .
Launched in November 2016, Cera is a technology-enable care company which has grown rapidly to become one of the largest home care providers in the United Kingdom, as well as one of fastest-growing healthtech businesses in Europe. Cera has nearly 6,000 staff across more than 70 offices in England, Scotland and Wales, and delivers around 30,000 care visits each day.
The company has pioneered machine learning, AI and data analytics technologies to transform the care sector – empowering users to live longer, healthier and better lives at home by supporting care workers and predicting changes in the health of users faster than traditional methods. More than 85% of carers using Cera’s app believe it enables them to deliver a safer and more effective service.
With plans to double the business’s headcount through 2021, Cera has established partnerships with a range of public and private sector organisations including the NHS, the Department for Health & Social Care, IBM, Deliveroo and Uber. Cera is actively recruiting for thousands of new care roles, and is a recruitment technology partner of the UK government for the wider care sector through the Join Social Care initiative.
These technologies, and Cera’s carer network, have been recognised through 30+ industry awards including Most Outstanding Home Care Provider from Home Care Insight from the Home Care Awards, Health Start-Up of the Year. Cera was co-founded by entrepreneur, physician and policy expert Dr Ben Maruthappu, and its advisory board is chaired by Sir David Behan, the former CEO of the Care Quality Commission..
Orchard Therapeutics is a leading global fully integrated commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies. Orchard’s portfolio of autologous ex vivo gene therapy programs has demonstrated sustained clinical benefit in over 150 patients across five disease areas.
These programs include Strimvelis®, the first autologous ex vivo gene therapy approved by the EMA in 2016, 3 programs in advanced registrational studies in MLD (metachromatic leukodystrophy), WAS (Wiskott Aldrich syndrome) and ADA-SCID (adenosine deaminase severe combined immunodeficiency), 2 other clinical programs in X-CGD (X-linked chronic granulomatous disease) and beta-thalassemia, as well as an extensive preclinical pipeline. The company is partnered with world-leading institutions in gene therapy, including University College London, Great Ormond Street Hospital, the University of Manchester and Central Manchester University Hospitals, the University of California Los Angeles and Boston Children’s Hospital, and Telethon Institute of Gene Therapy/Ospedale San Raffaele.
Orchard is a publicly traded company (NASDAQ: ORTX) with offices in the UK and the US, including London, San Francisco and Boston.. .
They provide anti-money laundering (AML) and know your customer (KYC) services for virtual currencies and blockchain actors. They enable traditional financial institutions and regulators to safely engage with the crypto world.
Their Trudatum product gives users the ability to register and authenticate any type of data, providing instant, secure online confirmation of the authenticity of documents and other files.. .
Healthily by Your.MD
Healthily is the world’s first medically approved self-care app designed around you. Combining responsive AI with trusted insights and tools, we match your personal needs to the latest information from doctors and healthcare specialists.
So you can understand your health and take the next step with confidence, wherever you are. Used by millions of people all over the world, Healthily’s pioneering approach to online clinical safety has attracted the support of leading investors and health organisations..
Zava is an online doctor service in which real GPs prescribe real medicines in real time. Zava offers trustworthy, affordable and regulated medical consultations without the need for a face-to-face visit.
Zava is a discreet and convenient way to get medical treatment, wherever and whenever you need it. No unnecessary questions.
And you don’t have to see a doctor in person. Their team are dedicated to helping you stay on top of your health.
Simply complete a medical questionnaire, place your order and their doctors will check the treatment you’ve requested is suitable for you, or recommend an alternative. Once they’re happy, your order will be sent out safely and securely to your chosen address.
Their service doesn’t end when you receive your order. If you have any questions at all about your treatment or condition, you can contact one of their doctors free of charge..
Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect, so that breakthroughs happen faster.
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK..
NightstaRx Ltd. is a U.K.
startup company. Gene therapy is the use of a gene to treat disease.
The approach could enable treatments for a several rare conditions caused by mutations in a single gene.. .
All the software that serves as the foundation of the market will be developed in open source. Commissions are zero.
We anticipate ample trade volumes. Our revenue will come from providing liquidity, offering issuance services, and supporting institutional clients..
Whether you’re a patient recovering from knee surgery or a desk worker starting to feel an ache in your back, the first step to getting you back to your best is getting an accurate measurement of your issue. Vitrue’s products accurately and objectively measure musculoskeletal issues from the workplace to the clinic.
Vitrue VIDA uses a desk worker’s webcam to assess their posture, desk ergonomics and several other aspects of their workplace wellbeing (including burnout risk). Vitrue EVVA uses depth sensors to perform clinical grade assessments of patients and is used in orthopaedics, elite sport injury prevention and preventative health screening..
In March 2018, CoinfloorEX joined the Coinfloor family, offering the first ever physically delivered cryptocurrency futures and spot exchange. Coinfloor’s client on-boarding process is strictly modelled against regulatory standards for AML and KYC.
Coinfloor established industry best practice by being the first exchange to publish monthly Provable Solvency reports. Their commitment to transparency and regular auditing instills client confidence that Coinfloor has sufficient cryptocurrency liquidity to manage market fluctuation.
Coinfloor investors include globally recognised venture capital firms and strategic investors. They are proud to have attracted funding from Passion Capital and Taavet Hinrikus.
Baby2Body is the number one app for women to keep healthy and happy during and after pregnancy. The app is a fully automated health, fitness and wellbeing coaching platform for pregnant women and mothers, helping women to optimize their health and wellbeing.
Based on multiple data points from each user, they use machine learning and proprietary, evidenced based content, to deliver personalised information and lifestyle advice: fitness, nutrition, psychological and emotional wellbeing and updates on the growth and development of their baby. Backed by science and expert -led, the company has reached over a million women in 100 countries, and continues to grow..
Acurable is a fast growing MedTech start-up headquartered in London. We commercialise the first wearable medical device able to accurately diagnose and manage respiratory conditions in a non-invasive way.
Our award-winning patented technology is a major engineering innovation and the product of 10 years research at Imperial College London. – Accurate : 5x more accurate readings than current solutions, enabling automated diagnosis and drastically reducing misdiagnosis.
– Easy to use : non-invasive and no training required, enabling home use without the assistance of a specialist or a visit to the hospital, which significantly lowers overall costs. We aim to understand human biosignals so well that nobody dies of a treatable condition ever again.
To achieve our objectives, we are building a team of exceptional people who are inspired by our vision, share our values, and who have the attitude and skills required to help Acurable succeed.. .
Rightangled delivers in-depth testing services with reports reviewed by registered medical and fitness professionals, in order to give its users a comprehensive understanding of their results and how to action their reports with tailroed plans. All their tests are carried out in ISO-accredited labs and reviewed by medical and fitness specialists from around the world.
Their model is based on the gig economy and pays its’ partner specialists per test review. Rightangled was backed by NHS England (a world-renowned national healthcare service provider in the UK) and registered by the Care Quality Commission in the UK as a healthcare provider.
Rightangled aims to deliver actionable and reliable advice to its users and be the hub for all screening and diagnostic services to all its’ members.. .
Award-winning eQuoo, the evidence-based Emotional Fitness Game, combines the excitement and joy of the gaming industry and the expertise of mental health professionals to provide a new form of mobile prevention and therapy. The game is designed for young adults aged 18-28 and is backed by academic research led by Psychologist Silja Litvin.
eQuoo users are five times more engaged than average mental health app users, making the game a pioneer in sustainable and scalable mobile therapy. eQuoo was successfully tested in a 5-week, 3-arm randomized controlled trial, proving that it significantly boosts resilience, interpersonal relationship skills, personal growth and lowers anxiety.
The game scores 85% with ORCHA and is being accepted into the NHS App Library. The company behind eQuoo is backed by Techstars, and has partnered with many charities, including Mental Health America and has caught the attention of major news outlets like Forbes and TechCrunch.
They are gearing up to conduct the biggest clinical trial around a mental health app in the UK with UCL and 45k students in September testing for depression and anxiety.. The app is built using technologies for today and tomorrow such as AI, Robotics, streaming and shortly launching our FanCoin on the blockchain.
It is a seamless blend of SportsTech with business opportunities, which connects billions of fans around the globe, opening the door to greater interactivity, collaboration, communication and personalisation that has never been experienced before. The powerful concept behind the revolutionary app is supported by several key features, which facilitates hugely immersive fan engagement, with fans creating and contributing their own football-focused content with a ‘by the fans, for the fans’ ethos.
Fans can connect and follow fellow fans or their friends or their beloved club to get involved in fan stories, videos, highlights, opinions, banter rooms, reactions to the latest results along the way also get rewarded with our FanCoin rewards. With ever-growing Football fans across every continent on the planet, ‘Football Fan’ is strategically placed with the right level of support to achieve the vision of becoming the go-to app for anything to do with Football..
Intelligent MSK devices and cloud analytics platform for an objective, data-driven approach to MSK care. Finalist in IET Innovation Awards, British Engineering Excellence Awards and Sports Technology Awards.
Secured £0.4m from Innovate UK’s ‘Digital Health in a Connected Hospital’ funding competition to develop MUJO’s connected healthcare technology and run an independent evaluation with patients and clinicians at The Royal National Orthopaedic Hospital NHS Trust.. .
ZoomDoc provides great care, either face to face or via smartphone for video and telephone consultations. It is an app-based health technology company delivering on-demand Doctors for home visits and telemedicine consultations.
It was founded by GPs, built by GPs, and run by GPs and provide the best possible on-demand GP service. ZoomDoc was founded in 2015 and is based in London, England..
Valirx Plc, an investment holding company, engages in the research and development of oncology therapeutics and diagnostics in the United Kingdom. The company principally offers VAL 101 that acts to shut down the Bcl-2 gene, a proto-oncogene.
It develops human papilloma virus diagnostic products based on the Nucleosomics, a platform for non-invasive tests for early cancer diagnosis based on epigenetic signal changes associated with malignancy; and HyperGenomics, a platform for differential diagnostic and prognostic tests in cancer, as well as testing for personalized medicine. The company also develops GeneICE compounds, which treat various diseases by acting to shut down harmful genes and prevent their expression.
Valirx Plc is based in London, the United Kingdom.. Every matchup counts towards your global Dugout FC ranking.
Earn trophies and awards. Brag about your managerial genius with your personal manager profile.
Live, pre-game drafts mean that every team in your league is completely unique. You own your players exclusively so you can start trading with your fellow managers or dip into the free agent pool and grab a bargain.
Their scoring model is the best in the business. They use Opta’s most detailed feed to analyse over 2000 match events in every game, to ensure that the best players in each position score points for their performances, not just goals and assists.
SERG Technologies is re-defining the way we interact with technology by creating reliable and functional wearables that can be used for activity tracking, monitoring health and fitness, and gesture recognition for smart devices. Our unique sensors detect tiny, subconscious movements that indicate a wearer’s intent, we turn these into control signals for everything from TV’s to smart prosthetics, resulting in almost instant response times.
We are also developing new tools to allow Parkinson’s patients to track their symptoms, providing vital new information to their doctors, leading to long term improvements to the efficacy their treatment. SERG was founded to make the gesture control of technology accessible for everyone and easier to use than ever before..
Even when a user does find a game, 72% are uninstalled after being played just twice. By using an app store, users see less than 1% of the games available to them, the majority of these from the large studios with bigger marketing budgets.
Why Now: Another 1 billion people are expected to gain access to the internet in the next 3 years through mobile. Growing up truly mobile-first they’ll discover all their entertainment, including games via their phones.
Mobile gaming has reached the point of max-saturation, the app stores are overfilled and advertising is pulling customers in every direction to download games. The recent growth of Artificial Intelligence algorithms, combined with the mass scaling and low cost architectures provided by Amazon and Google, now allow for extremely personalised experiences, distributed across mobile phones around the world in any language..
Smart Matrix is a medical device manufacturing company that specializes in wound care, regenerative medicine, and medical devices. It focuses on commercializing products based on a proprietary platform technology developed by the Restoration of Appearance and Function Trust.
The company was founded in 2011 and headquartered in England, United Kingdom.. .
Microtest Diagnostics was spun out of London’s Imperial College in 2002 with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&D investment, Microtest Diagnostics recently CE-marked the ADAM™ instrument.
The company operates with a highly skilled team of trained professionals with expertise across numerous fields including product, software and hardware design, instrument and assay development, regulatory approvals and quality control. Our facilities are certified ISO13485:2003 Medical devices and ISO 9001:2008 for the design and development of microarray test devices..
Through the combination of human and artificial intelligence we will be able to provide companies and agencies with intelligent visual content at highly efficient workflows.. .
ZiO Health have developed novel biosensor platform technology that quantitatively analyzes parameters in different bodily fluids (and other fluids). We develop a range of portable testing devices for the home, hospital and environmental applications based upon ZiO’s proprietary biosensor technology.
We operate under two brands, ELAPTA & ELOSIA Elosia is a home urine test for measuring wellness parameters to give personalised nutrition and wellness advice. .
Kolabtree helps organizations hire freelance scientists and researchers from across the globe, offering a secure space where they can find, hire and pay experts easily. Kolabtree’s global pool of experts have helped businesses develop new products, researchers get their papers published, and nonprofits take data-driven decisions.
With experts in over 2,000+ subjects, services range from data analysis to medical writing.. .
APCER Life Sciences
APCER Life Sciences provides comprehensive drug safety/pharmacovigilance, medical information, medical writing, regulatory services, quality assurance and risk management programs to pharmaceutical and biotech companies globally. We bring medicinal / scientific expertise through our healthcare professionals & physicians and address full pharmacovigilance requirements for North America, UK & Europe markets.
Our clients benefit from our vast experience in regulatory submissions across 100+ countries and consultative approach towards audit /inspection readiness. Our focus towards Patient safety and Risk profile management makes us the preferred choice for pharma companies who are looking for pre /post marketing compliance & reporting solutions.
We have scalable operations across five global offices which house more than 750 employees: Princeton, NJ, USA; London, UK; Germany, Wan Chai, Hong Kong, New Delhi and Ahmedabad, India.. .
EQL is a health and wellness company that specializes in the fields of AI, machine learning, physiotherapy, insurance, health tech, and digital health. It focuses on improving clinical pathways through technology, democratizing healthcare, and making it accessible.
The company was founded in 2018 and headquartered in London, England.. .
The global market for printed photo merchandise and gifting is over $10 billion and is growing at around 15% per year.” PRYYNT keeps the user in-app, and close to the image source, making photo printing more convenient and accessible. This is a value-add, in-app user experience and an obvious solution for apps that don’t wish to bombard their users with 3rd party advertising.
PRYYNT’s advisory board includes some of the leading specialists in printing, design, image management software and private equity. PRYYNT was founded in 2013 by entrepreneur James Washer whose background in printing and software helped him to combine image management, workflow and printing technologies to create PRYYNT.
PRYYNT successfully raised its first round of angel funding from private investors to build its business and is well positioned to access growth capital to scale rapidly.. .
NetScientific PLC is a life sciences and sustainability technology investment and commercialisation group. The group leverages trans-Atlantic relationships and global opportunities to deliver shareholder value and looks to maximise shareholder returns through focused execution of our investment strategy with current portfolio companies, and targeted investments in existing and new investment opportunities. NetScientific develops a customized investment and realisation strategy for its portfolio companies, seeking to enable the companies we work to access the right type of funding, proactive management support and resources specific to their sector, stage of development and available opportunities. NetScientific is a holding company of its various technology businesses.
Cancer Research Technology
Cancer Research Technology (CRT) develops and commercialises exciting new discoveries in cancer research. They’re the meeting point between academia and industry.
Their deep understanding of both perspectives enables them to translate promising research into commercial propositions for the greatest patient benefit and maximum financial return. CRT is uniquely placed to capitalise on the research and connections of theirr parent organisation Cancer Research UK, the world’s largest charitable funder of cancer research and the strong links they’ve established with leading clinical and academic institutions, pharmaceutical companies and biotechs worldwide.
CRT has 30 years’ specialist experience in the commercialisation of cancer research and a proven track record of successful innovation. CRT personnel are experienced, dedicated and highly motivated with an average length of service of nearly 6 years.
The workforce is split between drug discovery and commercialisation for a comprehensive approach to getting breakthrough therapeutics to patients.. .
Since its inception in 2014, Tatakoto set out to disrupt the field of medical diagnostics by bringing mobile lab grade test results to people’s homes. Their innovative solution enables performing a wide array of health tests using just a micro fluid sample with instant results.
Individualized and highly targeted programs are paving the path to removing the limits of health and human life span. Their team combines vast R&D experience in laboratory testing technologies and devices, entrepreneurial acumen and prior experience of building and growing companies from Start Up stage to 100mil+ annual revenue.
We are operating around the World and continue their quest to improve the life of each human being.. .
Optima Diagnostics Limited specializes in the design, development, and provision of Web-based systems for workplace health and safety management. It offers an Internet-based information management and analysis tool, the Wellworker system.
The company serves the public, private, and charity sectors. It offers a range of tools grouped into logical modular components.
Its modules include occupational safety module, including risk assessment, audit and inspection, maintenance and permits, contractor management, incident reporting and investigation, and training and competency management.. .
Harley Street Dental Clinic
Harley Street Dental Clinic offers cosmetic, general, and children dentistry services for its customers. Furthermore, it offers dental implants, bridges, dentures, white fillings, crowns, orthodontics, and more.
Harley Street Dental Clinic offers its international customers with translation services for Japanese, French, Arabic, French, and Italian clients. It facilitates a website that enables its users to find information about its services and payments.
Harley Street Dental Clinic was founded in London, England.. .
The cost of access to good quality healthcare is rapidly increasing beyond most people’s level of affordability. Access is also highly uneven across socioeconomic communities.
We believe health care should be readily available to all, regardless of socioeconomic standing. Our mission is to ensure our solutions maximize the use of readily available resources such as ambient light and personal devices such as mobile phones and tablets.
This leads to greatly reduced costs, vastly increased ease of use and rapid global deployment. Environmentally, our impact footprint is zero as our technology does not generate any harmful radiation.
Miznee has launched a pioneering digital healthcare marketplace for buyers and vendors of digital healthcare. We have developed and provided three highly innovative digital health assessment and therapy tools for vendors such as healthcare providers to use to deliver digital healthcare services.
The tools enable highly personalized and AI driven digital self-assessment and therapy from physical to psychological health concerns. Any language and media content support is included.
These digital health products are Perdeca, a triage and psychotherapy application, Miznee Mirror for skin care subskin imaging and Miznee X-Sense which enables x-ray images to show soft tissue and greater detail. To maximize privacy and HIPAA as well as GDPR compliance our solutions are anonymized and securely hosted with hosting partners in the US.
Imanova has world-leading expertise in imaging sciences and their application to the understanding of disease and translational drug development. An innovative joint venture, Imanova’s shareholders are the UK’s Medical Research Council and three world-class London universities: Imperial College London, King’s College London and University College London.
Imanova is a company with a depth of understanding in drug development and extensive experience using imaging to facilitate the development pipeline. Our academic expertise and extensive links with clinicians and scientists in our shareholder institutions provide unrivaled capabilities to facilitate drug development..
The concept was conceived during the Mobile World Congress in Barcelona with the coming together of experts in digital media, technology and creative with the aim to pioneer a new form of display advertising to engage audiences on smartphones. Today, Odyssey’s ‘end-to-end’ solution, is powering mobile advertising campaigns for some of the world’s leading advertisers including Nike, Lexus, The European Commission, Zurich Financial Services, Samsung and Warner Brothers to name a few.
Odyssey is rapidly expanding its international footprint with the opening of offices across the UK, Europe, Asia and USA. Odyssey’s focus is to deliver high impact brand advertising in premium environments across multiple markets, offering advertisers transparency, effectiveness and accountability.
Through our leading technology platform, premium publisher partnerships and high standards of creative design, we want to deliver results to our advertisers and become a leader in the mobile advertising space across the globe.. .
TheraGenetics was spun out of King’s College London in April 2006. Their technology is based upon pharmacogenetics; the study of genetic factors involved in influencing an individual’s response to drug treatments.
The strong foundation of TheraGenetics stems from the founding team’s long commitment to pharmacogenetics that has situated us at the cutting edge of personalised medicine. Under the umbrella of the Institute of Psychiatry at King’s College London, the founding team translated 15 years of research into the commercial world by developing the first pharmacogenetic test for response prediction in psychiatry.
In 2005, this test which focuses on the schizophrenia treatment clozapine, was successfully licensed by King’s College London to a major UK laboratory who have successfully brought the test to market in 2006. Based on this achievement and the overwhelming enthusiasm for personalised medicine solutions, King’s College London, the academic founders and the London based venture firm IPGroup PLC launched TheraGenetics in April 2006.
TheraGenetics unique knowledge and experience in CNS disorders extends from the bench to the bedside. The ultimate clinical utility has been a priority consideration at all stages of their test development; their clinical team knows what is required at the patient care interface and they develop tests accordingly.
The TheraGenetic’s team has a threshold of knowledge and experience spanning the whole test development process that is now allowing us to rapidly advance their work in the field of pharmacogenetic response prediction.. .
Evidence is mounting rapidly with regards to the patient benefit of a prostate cancer care pathway guided by MR imaging and targeted biopsy. Clinicians at University College London Hospitals have been working over the past five years with researchers in UCL’s Centre for Medical Image Computing to develop an image fusion software for transperineal targeting of the prostate.
The resulting CE-marked SmartTarget® device is specifically designed to be agnostic to the clinic’s MR and ultrasound equipment, intuitive for the user, fast to set up and slipping easily into existing clinical workflows with minimal disruption. Having also benefitted from funding by the UK’s Department of Health and the Wellcome Trust, we are pleased to offer a system that is affordable for both the public and private healthcare sectors..
Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms.
The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects.
Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts..
MindZone Group was established to nurture and grow exemplary businesses within the fields of mental and behavioural health. Our aim is to put clinical excellence within reach for the growing number of children, young people and adults in need.
We acquire, develop and build outcomes driven services that are evidence-based. Services made more accessible and affordable through the innovative application of digital technology..
Prayer makes devotees more advantageous and happier like ruqyah.We shouldn’t implore just at time of need yet it would be in all circumstances and occasions. The confidence in the significance of petition and its every day practice may help the reviled feel better.Prayer might be the primary root to forestall evileye and blach enchantment .
Peole ought to atone and come back to Allah by watching the compulsory supplications, keeping away from disallowances, and recounting the morning and night notice of Allah.. .
These synergistic capabilities from our diverse interdisciplinary teams combine seamlessly to create unique solutions which mix cutting-edge technologies with innovative storytelling and immersive learning. We have offices in the UK (Midlands HQ & London), US (Orlando), China (Shanghai) and the UAE (Abu Dhabi).
Our work is carried out by our in-house global teams of specialist engineers, developers, creatives, producers, data scientists and project managers. Our list of highly-satisfied clients include Universal Studios, Comcast, Madame Tussauds, LEGOLAND Parks, McLaren, the British Museum, Ferrari World Abu Dhabi, Dubai Parks & Resorts, Jaguar Land Rover, Evergrande and Miral.
Our work rigorously complies with our proven Holovis Project Management System. This, combined with our ISO-9001 accreditation, provide a double-layer of quality control and service.
This means we deliver work correctly, professionally and on-time to our clients. .
ICDS Arch offers comprehensive data analysis, research and advisory services that align and helps senior executives and their companies to drive corporate performance by saving on key decisions which focus on the ease of effort to move swiftly when addressing emerging and enduring business challenges across the market. ICDS Arch tools, insights, and analysis, empower businesses to win customers by addressing key issues such as ad-hoc and intelligent measures when facing client acquisition.
ICDS Arch clients span over more than 50 countries with 1,300 in individual organizations and 530 in business professionals. For more information, visit http://www.icdsarch.com Over the years, our team has represented one of the fastest growing parts of ICDS Arch and has successfully helped many members implement ICDS Arch’s best practices research.
Solutions and the ability to leverage ICDS Arch’s intellectual property in the form of engagement execution, including the use of proprietary survey diagnostics, analyses, and quantitative models, has proven successful in numerous industries across these areas: · Sustainable developments in property market · Research and development of dwell like satellites · Capital engagement through intelligent identity · Web based applications and prototypes · R&D for public space and people behaviors. .
SpotOn Clinical Diagnostics Ltd.
SpotOn Clinical Diagnostics Ltd. is a spin-out from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust.
Its patented technology is based on 30-years of pioneering research by Professor Neil Dalton and Charles Turner of the WellChild Laboratory – a collaboration between King’s College and Evelina Children’s Hospital.. .
Activiomics Ltd. has developed a groundbreaking and patented technology that will enable a transformation in the way in which biomarkers are identified, diagnostics are developed and drug candidates are identified and profiled.
Activiomics’ technology centres around novel mass spectrometry based approaches for the global quantitative analysis of phosphorylation sites. Phosphorylation is critical mediator all cellular processes and hence sites of phosphorylation represent an important class of novel biomarkers.
Activiomics’ TIQUAS (Targeted In-depth QUAntification of cell Signalling) technology enables the quantification of thousands of phosphorylation events from a given tissue sample and the subsequent markers of response that are identified will enable the development of future diagnostics.. .
Cronos Therapeutics, Ltd., a biopharmaceutical company, develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer. Its GeneICE compounds represent a way of treating diseases by acting to shut down harmful genes and therefore prevent their expression.
The company’s HyperGenomics platform characterizes disease state by detecting areas on the chromosome where genes are active. Its compound, which is undergoing development, acts to shut down the Bcl-2 gene.
Cronos Therapeutics, Ltd. was founded in 2004 and is based in London, the United Kingdom.
As of October 3, 2006, Cronos Therapeutics Ltd. is a subsidiary of ValiRX PLC..
Forms on the Fly
Just launched, Forms on the Fly allows anyone to build and publish intelligent, interactive forms. With no programming required, anyone can use Forms on the Fly to create quizzes, questionnaires and diagnostics that entertain, inform or deliver support and training as well as generating leads.
Crucially, itâ€:tm:s not a survey tool. Quizzes and questionnaires built with Forms on the Fly donâ€:tm:t only collect information, they can easily be configured to deliver it too.
So, users can find out more about who is visiting their site, while their site visitors receive automated yet personalised feedback reports. For only Â£5 per month, bloggers can create an unlimited number of business diagnostics, womenâ€:tm:s magazine style quizzes, e-learning tools, quizzes, games, personality tests and more, all branded with their own logo and name, and easily embedded in their blogs with the HTML code provided..
You may write to us at: BestStartup.co.uk/Fupping Ltd, 349 Royal College Street, London, England, NW1 9QS.